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Abstract
Background: Non-suicidal self-injury (NSSI) is a transdiagnostic behaviour that can be difficult to treat; to date no
evidence based treatment for NSSI exists. Mindfulness Based Cognitive Therapy (MBCT) specifically targets the
mechanisms thought to initiate and maintain NSSI, and thus appears a viable treatment option. The aims of the
current study are to test the ability of MBCT to reduce the frequency and medical severity of NSSI, and explore the
mechanisms by which MBCT exerts its effect.
Methods/Design: We will conduct a parallel group randomised controlled trial of Mindfulness Based Cognitive
Therapy (MBCT) versus Supportive Therapy (ST) in young people aged 18–25 years. Computerised block randomisation
will be used to allocate participants to groups. All participants will meet the proposed DSM-5 criteria for NSSI (i.e. five
episodes in the last twelve months). Participants will be excluded if they: 1) are currently receiving psychological
treatment, 2) have attempted suicide in the previous 12 months, 3) exhibit acute psychosis, 4) have a diagnosis
of borderline personality disorder, or 5) have prior experience of MBCT. Our primary outcome is the frequency
and medical severity of NSSI. As secondary outcomes we will assess changes in rumination, mindfulness, emotion
regulation, distress tolerance, stress, and attentional bias, and test these as mechanisms of change.
Discussion: This is the first randomised controlled trial to test the efficacy of MBCT in reducing NSSI. Evidence of
the efficacy of MBCT for self-injury will allow provision of a brief intervention for self-injury that can be implemented
as a stand-alone treatment or integrated with existing treatments for psychiatric disorders.
Trial registration: Australian New Zealand Clinical Trials Registry Number ACTRN12615000023550. Registered 16
January 2015.
Keywords: Non-suicidal self-injury, Mindfulness based cognitive therapy, Randomised controlled trial
Background
Non-suicidal self-injury (NSSI), the deliberate destruc-
tion or alteration of body tissue without conscious sui-
cidal intent and for purposes not socially sanctioned [1],
is a transdiagnostic behaviour that is used to cope with
intense emotions and psychological distress. Equally
common among males and females, NSSI can include
cutting, burning or carving the skin and hitting or bang-
ing the self or hard objects. Although typically emerging
in adolescence, NSSI is most prevalent among 18–24
year olds (20 % lifetime history) [2]. NSSI differs from
suicidal behaviour (including ideation and attempts) in
being more prevalent, engaged in more frequently, typic-
ally involving non-lethal methods, and being driven by
emotion regulation rather than a desire to end life. As
such the aetiology of NSSI is markedly distinct from
suicidal behaviour, necessitating a tailored treatment
approach [3, 4].
In Australia, the direct hospital costs of non-suicidal
self-injury are estimated at over $14 million per month
[2]. Among 15–24 year olds, 7301 were hospitalised for
self-harm (including suicidal behaviour) in 2009–2010,
placing the direct cost in this age group alone at almost
$34 million per year [5]. With increased awareness and
* Correspondence: C.Rees@curtin.edu.au
1School of Psychology and Speech Pathology, Curtin University, GPO Box
U1987, Perth, WA 6845, Australia
Full list of author information is available at the end of the article
© 2015 Rees et al. This is an Open Access article distributed under the terms of the Creative Commons Attribution License
(http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium,
provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://
creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Rees et al. BMC Psychiatry  (2015) 15:154 
DOI 10.1186/s12888-015-0527-5
efforts to improve help-seeking [6], these costs are set to
rise dramatically unless effective interventions to minim-
ise the frequency and medical severity of the behaviour
are made available. Young people who self-injure carry a
fourfold risk of suicidal thoughts and behaviours within
the following year [7], and Australians who self-injure
are 42 times more likely to attempt suicide [2]. Reducing
the major risk factor of self-injury is crucial to suicide
prevention efforts yet there is no targeted evidence-
based treatment for self-injury.
Growing recognition of the prevalence and impact of
NSSI has led to its inclusion in Section 3 of the latest
edition of the Diagnostic and Statistical Manual of
Mental Disorders (DSM) [8], as a condition for further
study. Proposed criteria include: NSSI on five or more
days in the past year, for the purpose of relief from nega-
tive feelings, resolving interpersonal difficulties or to
induce a positive state (e.g. euphoria). NSSI is defined as
being associated with negative thoughts and feelings,
premeditation and rumination. The proposed criteria
evidence discriminant validity [9–11].
Commensurate with the affect-regulatory function of
NSSI, mechanisms thought to increase risk of NSSI in
the face of stress include poor emotion regulation, poor
distress tolerance and rumination on negative thoughts
and feelings. Emotional cascade theory proposes that
through rumination even minute emotional stimuli be-
come amplified over time [12] and, in the absence of
adaptive emotion regulatory strategies, individuals self-
injure to escape the subsequent cascades of intense
emotion. Supporting this, researchers consistently dem-
onstrate increased arousal and rumination prior to NSSI
[13, 14], higher physiological reactivity and poor distress
tolerance when under stress [15], and emotional relief
and reduced arousal after NSSI [16].
Treatment for NSSI
Despite the adverse outcomes for people who engage in
NSSI, there is no empirically validated treatment avail-
able [17]. Where NSSI is an outcome variable of interest
in clinical trials, treatment has been exclusively designed
for people with Borderline Personality Disorder (BPD)
[18–20]. Given the transdiagnostic nature of NSSI, treat-
ments that address NSSI beyond BPD are essential.
Mindfulness-Based Cognitive Therapy (MBCT) was de-
signed specifically to impact on attention to negative
thoughts and images, emotion regulation, distress toler-
ance and rumination [21, 22], and successfully evidences
reductions in emotional reactivity [23]. That this treat-
ment directly addresses proposed diagnostic features of
NSSI, and core mechanisms repeatedly implicated in
NSSI [8], offers immense promise for MBCT as a treat-
ment for NSSI. Yet, despite recent work implicating a
lack of mindfulness in the maintenance of NSSI [24], no
prior research has explored the ability of MBCT to im-
pact the frequency and medical severity of NSSI. Garner-
ing support for MBCT as a viable and efficacious
treatment is essential to the on-going effort to reduce
the impact and burden of NSSI.
If, as theorised, MBCT exerts its effect by minimising
attention on negative thoughts and rumination, improv-
ing distress tolerance and emotion regulation, and
reducing perceived and physiological stress responses,
changes in these variables should be evident upon
completion of an MBCT program, with subsequent
improvement in NSSI. Assessing mechanisms of change
is crucial to determining the ‘active ingredient’ in MBCT,
facilitating optimal outcomes and tailored treatment
approaches [25].
The current study
In this study we aim to: 1) determine the efficacy of
group Mindfulness Based Cognitive Therapy (MBCT) in
decreasing the frequency and medical severity of Non-
Suicidal Self-Injury (NSSI) among young people, relative
to group Supportive Therapy (ST); and 2) establish the
mechanisms by which MBCT reduces frequency and
severity of NSSI. The following hypotheses are proposed:
1. We expect MBCT to reduce the frequency and
medical severity of NSSI, relative to ST and this
reduction to be maintained at 3 month and 6 month
follow-up
2. We expect MBCT to increase mindfulness, reduce
rumination, improve emotion regulation, improve
distress tolerance, reduce bias for negative stimuli,
and reduce stress (self-reported and physiological,
based on cortisol)
3. We expect the proposed mechanisms of action will
mediate the relationship between assigned treatment
group and outcomes of reduced NSSI, lower scores
on the Beck Anxiety Inventory, and lower scores on
the Beck Depression Inventory-II (Fig. 1).
Methods/Design
Study design
We will conduct a parallel group randomised controlled
design in which half our participants receive Group
Mindfulness Based Cognitive Therapy and half receive
Group Supportive Therapy. We will implement a com-
puterised block randomisation procedure to ensure
equal distribution of participants across conditions
(Fig. 2). As far as practically possible participants will
be blind to group allocation. Self-report, behavioural
and physiological measures will be administered at
pre-treatment, mid-treatment, post-treatment, and 3
and 6-month follow-up. To maximise external validity, a
minimum follow-up period of 6 months is recommended
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and will be adopted in the present study [26]. Baseline
assessments and follow up assessments will be conducted
by a researcher blind to group allocation.
Participants and recruitment
We will recruit 96 participants (48 per group) via our
existing referral networks of GPs, mental health profes-
sionals, and university counselling services, as well as
through advertising in print media and social network
sites. Inclusion criteria include: 1) Aged 18–25 years,
and 2) meet proposed DSM-5 criteria for NSSI [8].
Participants will be excluded if they: 1) are currently
receiving psychological treatment, 2) have attempted
suicide in the previous 12 months, 3) exhibit acute
psychosis, 4) have a diagnosis of borderline personality
disorder (BPD), or 5) have prior experience of MBCT.
As NSSI is one diagnostic criterion for BPD, young
people diagnosed with BPD will be excluded to avoid
confounding diagnosis and behaviour. Individuals pre-
senting with suicidal behaviour, psychosis or BPD will be
appropriately referred.
Intervention
A trained psychologist will conduct telephone interviews
to assess eligibility with the single-item Clinician-Rated
Severity of Non-Suicidal Self-Injury [27] and 6-item
Mini International Psychiatric Interview [28]. Both treat-
ment conditions will comprise 8 weekly group sessions
of 2 h duration with up to 12 participants in each group.
All group sessions and assessments will occur at the
Curtin University Psychology Clinic. As per standard
practice, two trained therapists, blind to the results of
baseline and follow-up assessments, will facilitate each
group. Suicidality will be monitored weekly throughout
treatment (both conditions) using the 3-item Self-
Monitoring Suicide Ideation Scale [29].
To ensure treatment fidelity, each therapist will receive
training and weekly supervision. All treatment groups
will be audiotaped with 10 % checked to ensure adher-
ence to manualised treatment protocols, using the
Mindfulness Based Cognitive Therapy Adherence
Scale for MBCT group [30]. At the first treatment ses-
sion all participants will complete the 6-item Credibility/
Expectancy Questionnaire [31] to assess treatment face
validity. We will assess treatment acceptability using Dear
et al’s [32] 4-item acceptability rating scale. Upon comple-
tion of treatment, participants will also provide open
comments about acceptability, and specify intended NSSI
prevention strategies.
Mindfulness-based cognitive therapy (MBCT)
We will utilise the standard MBCT treatment protocol
[21]. Each session combines key elements of cognitive
therapy with training in mindfulness meditation. Partici-
pants are taught skills designed to foster present
moment awareness which include practising mindfulness
meditation, body scan, mindful walking and stretching.
Cognitive therapy techniques include education about
the role of negative thoughts and how rumination,
avoidance, suppression, and struggling with unhelpful
cognitions and emotions can perpetuate distress rather
than resolve it. Participants learn to identify patterns of
emotional response and negative thinking that act as
warning signals for NSSI and help one another to
develop crisis plans and actions to take in the event of
future NSSI urges.
Supportive therapy (ST)
Supportive therapy is a widely used active control condi-
tion in psychotherapy outcome studies, as it controls for
both the non-specific effects of any psychological
intervention (i.e. therapeutic relationship) and the
unique aspects of group therapy (i.e. social support).
Additionally, from an ethical perspective, the group
support condition ensures that no participants are left
without an intervention. We will use Borkovec and
Costello’s [33] manualised protocol. In ST, the therapist
provides empathy, fosters a supportive environment, and
facilitates discussions among group members around
NSSI and other life issues. No MBCT techniques are
taught by the therapist.
Ethical issues
After initial telephone screening to assess eligibility, dur-
ing which participants are verbally informed of the study

















Fig. 1 Hypothesised model
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detailed information sheet which outlines the aims and
participation requirements of the study, informs partici-
pants of the confidential and voluntary nature of
participation, and outlines how data are to be collected,
used and stored in accordance with relevant Privacy
Legislation. All participants will be afforded the oppor-
tunity to ask questions about the study and will provide
signed consent to participate in the research project.
Participants are free to withdraw from the research
project at any time.
There is some concern regarding the potential for so-
cial contagion when discussing NSSI in a group setting.
Our experience and a growing evidence base, suggests
that when appropriately addressed, iatrogenic effects are
rarely observed [34]. Conversely, research indicates that
participants benefit from being asked about their NSSI
[35, 36]. We will minimise risk of iatrogenic effects by
following established guidelines to reduce social conta-
gion [37], including discouraging sharing of explicit
details, NSSI images or scars in the group setting.
This conduct of this trial has been approved by the
Curtin University Human Research Ethics Committee
(Ref number: 4884).
Clinical outcome measures
Self-injury monitoring diary: Participants will complete
the Self-Injury Monitoring Diary, developed for this study,
across the course of the trial, to assess ongoing frequency
and medical severity of NSSI. Each day participants will
indicate whether they had an urge to self-injure, the
strength of this urge, whether they did self-injure, and the
severity of the injury.
Clinician-rated severity of Non-suicidal self-injury
[27]: This single item scale assesses the severity of
NSSI on a scale of 0 =None; 1 = Sub-threshold; 2 =Mild;
3 =Moderate; and 4 = Severe. The measure was designed
to capture clinically meaningful changes in NSSI severity,
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Fig. 2 CONSORT flow diagram of participant allocation
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based on the proposed DSM-5 criteria [8]. Therapists will
rate each participant at the end of each therapeutic session.
Beck depression inventory - 2nd Edition [38] (BDI-II):
The BDI-II is a 21-item measures of depressive symp-
toms, each rated on a four-point scale. Both a continu-
ous measure indicating severity of symptoms, and
clinically meaningful cut-off scores can be obtained. The
BDI-II is the gold-standard questionnaire assessment of
depression and demonstrates acceptability as a screening
tool in both healthy and clinical populations [39, 40].
Beck anxiety inventory [41] (BAI): The BAI is a
21-item assessment of anxiety symptoms experienced in
the last week, with each symptom rated on a four-point
scale. Both cognitive and somatic symptoms are
assessed. As the gold standard questionnaire assessment
of anxiety, the BAI demonstrates excellent psychometric
properties [41].
Mechanism of change measures
Cognitive and affective mindfulness scale - revised
[42] (CAMS-R): The CAMS-R is a brief (12 item) self-
report measure designed to assess the capacity an indi-
vidual has to be mindful. The measure demonstrates
internal consistence and convergent validity with similar
measures when administered to university students [42].
Ruminative thought style questionnaire [43] (RTSQ):
The RTSQ is a 20-item measure describing positive,
negative and neutral facets of global rumination (e.g.,
“I can’t stop thinking about some things” or “I have
never been able to distract myself from unwanted
thoughts”). Respondents rate each statement on a
7-point Likert scale (1 = not at all descriptive of me,
7 = describes me very well). The RTSQ has demonstrated
good convergent validity with the Response Style
Questionnaire, the Global Rumination Scale and the
Beck Depression Inventory, adequate test-retest
reliability and high internal consistency [43].
Difficulty in emotion regulation scale [44] (DERS):
The DERS uses 36 items to tap into 5 aspects of emo-
tion regulation: non-acceptance of emotional response,
difficulty in goal directed behaviour, impulse control,
emotional awareness, lack of emotion regulation strat-
egies and emotional clarity. Participants respond to each
item on a 5-point scale. The measure demonstrates
acceptable reliability in university students as well as
content and convergent validity [44].
Distress tolerance scale [45]: This 14 item self-report
measure assesses an individual’s ability to withstand feel-
ing distressed. The scale assesses an individual’s ability
to tolerate emotions, their appraisal of emotional situa-
tions, how absorbed they are by negative emotion and
emotion regulation using 5-point Likert scales.
Perceived stress scale [46]: The Perceived Stress Scale
is a 10-item assessment designed to provide a global
assessment of perceived stress. Items assess how unpre-
dictable, controllable and overloaded individuals find
their lives, without reference to specific events. The scale
evidences discriminant validity with depression, and
internal consistency [46].
Cortisol measurement: Both cortisol awaking response
(CAR) and daily slope (DS) will be assessed to obtain
total daily cortisol output. Cortisol is a biomarker of
stress and anxiety [47], and varies in response to stress
among people who self-injure [48, 49]. Following best
practice [50] we will collect saliva on two consecutive
days at each data collection point. On each of these days,
participants will collect saliva upon waking, 30 and
45 min after waking (CAR) and again at 4, 9, and 13 h
after waking (DS). To increase adherence to the protocol
participants who comply with at least 80 % of saliva col-
lection will receive a $50 iTunes voucher. Participants
will use Sarstedt Cortisol Salivettes® to collect saliva,
which provides an easy and hygienic collection method,
further encouraging compliance. Saliva is obtained by
chewing on a synthetic swab which is then placed in the
container for safe transportation to the laboratory for
analysis. Importantly, the Salivettes® are designed to
allow reliable analysis from small saliva volumes and low
cortisol levels. Following collection, we will recover the
saliva from the Salivettes®, centrifuge and store in
aliquots at −80 °C until analysis using an enzyme-linked
immunosorbent assay (ELISA). Participants will record
waking time and all sampling times, and bring their
clearly labelled samples to the subsequent assessment
session in the clinic.
Attentional bias The differential allocation of attention
to emotional stimuli can be assessed in simple reaction
time tasks that are presented using a computer. One of
these tasks is the so called ‘dot probe’, which assesses the
effect of emotional cues on the detection or identifica-
tion of a probe stimulus [51]. In this task, two pictures
or two words that differ in emotional valence (cues;
pleasant and neutral or unpleasant and neutral) are pre-
sented simultaneously for a short period of time in dif-
ferent locations on a computer screen, left and right half
or upper and lower half. After 500 ms, a probe stimulus
is presented in the location that was previously occupied
by one of the cues. The probe used in our task are two
dots either arranged horizontally ‘..’ or vertically ‘:’. The
participant’s task is to indicate the arrangement of the
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dots by pressing one of two buttons. Participants will be
faster to respond to the probe if their focus of attention
is at the location at which the probe is presented. If par-
ticipants are faster to respond to probes that replace
unpleasant cues, we conclude that attention is biased
towards the unpleasant stimuli indicating preferential
processing. If participants are faster to respond to probes
that replace neutral cues, we conclude that attention is
biased away from unpleasant stimuli indicating avoid-
ance. Pleasant stimuli are included to assess whether the
differential allocation of attention is driven by cue
valence (differs for pleasant and unpleasant cues relative
to neutral cues) or emotional arousal (is similar for
pleasant and unpleasant cues relative to neutral cues).
Cues will be pictures (neutral, pleasant, unpleasant, NSSI
related) drawn from the standardised International
Affective Picture System [52] and normed words
(neutral, pleasant, unpleasant, NSSI related) [53]. Cue
location will be counterbalanced (e.g. pleasant cues will
appear equally often in each possible location) as will be
relation of probe to cue (i.e., the probe will follow an
emotional cue equally often than a neutral cue - so cues
are not predictive of probe position). This results in 24
different stimulus configurations (trials) for a fully
counterbalanced design (3 × 2 × 2 × 2; cue valence
[pleasant, unpleasant, NSSI related] x cue location [top vs.
bottom/left vs right] x probe location [emotional,
neutral] x stimulus material [words, pictures]). These
24 stimulus configurations will be repeated 10 times
in a random order yielding a total of 240 trials.
Including practise trials, this procedure will take
approximately 10 min.
Sample size calculation and statistical analysis
We will perform both Intention to Treat and Per
Protocol analyses. We will conduct a sensitivity analysis
[54], and compare complete cases versus cases lost to
follow-up on baseline characteristics and scores on clin-
ical measures, by randomization group [55]. Mixed
Model Repeated Measures analyses will compare results
on outcome measures across conditions and time points,
while controlling for random effects (e.g. age, gender).
Using medium effect sizes [56] 40 per group are re-
quired for power = .80 and α = .05 (G*Power) [57].
Recruiting an additional 20 % (n = 48 per group) will
allow for typical dropout [58, 59]. Mechanisms of action
(see Fig. 1), will be tested using multiple mediational
analysis with 1000 bias-corrected bootstrap samples in
MPlus, to test total and specific indirect effects. This
powerful test of mediation requires a sample of 71 par-
ticipants to detect a medium effect [60]. Participants will
be classified into outcome categories (Recovered,
Improved, Unchanged, Deteriorated) [61] according to
Reliable Change Index and Clinical Significance of
change at post-treatment and follow-up, to determine
whether MBCT and ST differ in clinically significant
reductions in NSSI and associated symptoms of anxiety
and depression over time.
Discussion
Although delineated from suicidal behaviour by defin-
ition, people who repeatedly self-injure carry a fourfold
risk of suicidal thoughts and behaviours within the
following year [7], and are 42 times more likely to at-
tempt suicide [2]. Of note, NSSI increases risk of suicidal
behaviour over and above risk conferred by comorbid
psychopathology, adverse life events and psychosocial
risk factors [7, 62]. To reduce the physical, psychological,
social and economic burden of self-injury, effective
interventions are urgently needed [63]. MBCT is a trans-
diagnostic intervention that has established evidence in
the treatment of many clinical conditions. Importantly,
MBCT was designed specifically to focus on the very
mechanisms thought to maintain self-injury (i.e. ru-
mination, focus on negative thoughts, poor emotion
regulation). MBCT thus offers untapped potential for
reducing the frequency and medical severity of self-
injury.
This trial offers significant advantages over previous
efforts to determine effective treatments for NSSI. First,
the components of MBCT directly align with cognitive
and emotional factors related to NSSI, thus offering the
best chance of targeting the key mechanisms maintain-
ing the behaviour. Second, we will collect both self-
report and clinician ratings of NSSI severity through the
course of the project. These will be supplemented with
behavioural measures of attentional bias and analysis of
cortisol as a physiological measure of stress. These
objective measures significantly strengthen the scientific
rigour of the findings. Third, the active comparison
condition allows additional control over the influence of
group processes, therefore allowing a direct test of the
specific intervention mechanism of MBCT.
While the proposed sample size is small, the repeated
measures design ensures our study is sufficiently pow-
ered to identify medium effects on our primary outcome
variable, and provide preliminary assessment of the
mechanisms of change. Restricting our sample to 18–25
years necessarily will limit generalisation of the findings
to other age groups, however given this is the age at
which NSSI is most common [2] it seems the appropri-
ate age range to first test the efficacy of MBCT in redu-
cing this behaviour.
By directly addressing the mechanisms maintaining
self-injury irrespective of psychiatric diagnosis, group
mindfulness-based cognitive therapy (MBCT) offers
great promise as a transdiagnostic treatment that can be
a successful intervention for a greater number of young
Rees et al. BMC Psychiatry  (2015) 15:154 Page 6 of 8
people who self-injure. Establishing efficacy of MBCT
for self-injury will provide the first targeted evidence-
based treatment, giving therapists the power to intervene
confidently and produce positive outcomes for youth
who self-injure [64]. Outcomes of this project will sig-
nificantly improve the care given to those who self-
injure, improve their well-being, decrease their chances
of further self-injury, and decrease the chance they will
die by suicide.
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